Connor, Clark & Lunn Investment Management Ltd. Guardant Health, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$20.94 - $38.01 $3.16 Million - $5.73 Million	-150,820 Reduced 92.92%	11,493 $411,000
Q1 2023 May 09, 2023	BUY	$22.92 - $33.76 $3.33 Million - $4.91 Million	145,415 Added 860.55%	162,313 $3.8 Million
Q4 2022 Feb 10, 2023	BUY	$25.44 - $59.78 $429,885 - $1.01 Million	16,898 New	16,898 $459,000
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $288,218 - $391,277	-3,249 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $2.6 Million - $3.49 Million	-26,373 Reduced 89.03%	3,249 $406,000
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $2.55 Million - $3.85 Million	23,250 Added 364.88%	29,622 $3.68 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $809,498 - $1.14 Million	6,372 New	6,372 $973,000

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$411 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$394 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$355 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$243 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$211 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account